메뉴 건너뛰기




Volumn 21, Issue 2, 2015, Pages 272-274

Sofosbuvir, simeprevir, and ribavirin for the treatment of hepatitis C virus recurrence in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients

Author keywords

[No Author keywords available]

Indexed keywords

RIBAVIRIN; SIMEPREVIR; SOFOSBUVIR; ANTIVIRUS AGENT; FUSED HETEROCYCLIC RINGS; IMMUNOSUPPRESSIVE AGENT; SULFONAMIDE; URIDINE PHOSPHATE; VIRUS RNA;

EID: 84921792370     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.24027     Document Type: Letter
Times cited : (14)

References (2)
  • 1
    • 84861821680 scopus 로고    scopus 로고
    • Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection
    • Terrault NA, Roland ME, Schiano T, Dove L, Wong MT, Poordad F, et al.; for Solid Organ Transplantation in HIV: Multi-Site Study Investigators. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl 2012;18:716-726.
    • (2012) Liver Transpl , vol.18 , pp. 716-726
    • Terrault, N.A.1    Roland, M.E.2    Schiano, T.3    Dove, L.4    Wong, M.T.5    Poordad, F.6
  • 2
    • 84983238434 scopus 로고    scopus 로고
    • Advances in therapy for HIV-HCV coinfected patients in the liver transplant setting
    • Jan 1
    • Campos-Varela I, Peters MG, Terrault NA. Advances in therapy for HIV-HCV coinfected patients in the liver transplant setting. Clin Infect Dis 2015 Jan 1;60(1):108-116.
    • (2015) Clin Infect Dis , vol.60 , Issue.1 , pp. 108-116
    • Campos-Varela, I.1    Peters, M.G.2    Terrault, N.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.